Geron Corporation (NASDAQ:GERN) is one of the 10 Fastest Growing Tech Penny Stocks to Buy .
On June 18, 2026, Geron Corporation (NASDAQ:GERN) reported that, effective June 17, 2026, it granted stock options to purchase an aggregate of 690,000 shares of common stock to eight newly hired employees. The grants were made as an inducement material to the employees' acceptance of employment with Geron.
The stock options have an exercise price of $1.23 per share, equal to the closing price of Geron's common stock on the grant date. The options have a ten-year term and vest over four years, with 12.5% of the shares underlying the options vesting on the six-month anniversary of the employee's employment commencement and the remaining shares vesting over the following 42 months in equal installments, subject to continued employment.
15 States with the Best Healthcare in the US
Earlier in June, Geron Corporation (NASDAQ:GERN) announced that members of its management team were scheduled to participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference.
Geron Corporation (NASDAQ:GERN) focuses on the development of therapeutic products for oncology.
While we acknowledge the potential of GERN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy .
Disclosure: None. Follow Insider Monkey on Google News .
